1. InvaFreeHMS,Inc.
Miniature and Portable, continuous, long duration and a non-invasive platform for diagnostic devices.
InvaFreeHMS, Inc.
www.invafreehms.com
info@invafreehms.com
December, 2014

2. Company
InvaFreeHMS, Inc. is a Canadian company incorporated in 2009.
InvaFreeHMS designs, patents, manufactures and wants to sell its medical devices in the unmeet portable, miniature, continuous and non-invasive platform for the diagnostic niche markets.
The base technology of InvaFreeHMS is a portable and a miniature device for the non-invasive and continuous extraction of the interstitial fluid through the skin of living subjects.
Propriety of InvaFreeHMS, Inc., 2014-12-11
2

3. Market Position
The unmeet portable, miniature, continuous and non- invasive platform for the diagnostic niche markets.
Propriety of InvaFreeHMS, Inc., 2014-12-11
3

4. Market Position
Propriety of InvaFreeHMS, Inc., 2014-12-11
4

5. Immediately Available Markets
Our portable, miniature, continuous and non-invasive platform for the biomedical diagnostic is ready for the following markets:
Animal applications.
Pharmacodynamic/pharmacokinetic, toxicity studies, etc. of new drugs and drugs development on animals.
Academic and scientific research laboratories.
Medical Research centers, etc.
InvaFreeHMS is looking for investors/partners for the production and the launch of its technology for the above markets. There is no need for clinical trial for these markets.
Propriety of InvaFreeHMS, Inc., 2014-12-11
5

6. Human Healthcare Market
Problems solved by InvaFreeHMS devices
Non-invasive: No part of the device gets under or is inserted under the skin.
No equivalent product on the market: Completely out-of-body device.
Painless: No needles or blood are needed.
Universal: The extracted liquid allows the monitoring of all biomarkers like ions, from small to medium, large and ultra-large- sized biomarkers such as albumin and immunoglobulins.
Versatile and portable: Can be used on animals and humans.
Propriety of InvaFreeHMS, Inc., 2014-12-11
6

7. Human Healthcare Market
Problems solved by InvaFreeHMS devices
Continuous: the access to bio-markers can be performed for more than 3 weeks. We have verified it for glucose correspondence with blood samples.
Long-lasting: re-usable, out-of-body, greatly improves the lifetime and variety of sensors that can be used.
Essential: Non-invasive and continuous monitoring of diabetes, cardiovascular, Kidney, etc.
Special markets: military and sports markets for stress, trauma, exhaustion and dehydration.
Propriety of InvaFreeHMS, Inc., 2014-12-11
7